Answers are grounded in this paper and cite their sources.
Literature review enhances the design of clinical trials in pediatric IgA nephropathy, indicating potential benefits of extrapolation.
In conjunction with the similar biological basis of the disease in pediatric and adult patients, these findings may enable the use of extrapolation in the design of clinical trials in pediatric patients with IgAN.
No takes yet. Share an insight, caveat, or question.
Serpe et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: